Cargando…
Allergic eye disease: Blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells
Autores principales: | Eskandarpour, Malihe, Zhang, Xiaozhe, Micera, Alessandra, Zaher, Sarah, Larkin, Frank D. P., Nunn, Miles, Bonini, Stefano, Weston‐Davies, Wynne, Calder, Virginia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292376/ https://www.ncbi.nlm.nih.gov/pubmed/34614221 http://dx.doi.org/10.1111/all.15128 |
Ejemplares similares
-
Immune-Mediated Retinal Vasculitis in Posterior Uveitis and Experimental Models: The Leukotriene (LT)B4-VEGF Axis
por: Eskandarpour, Malihe, et al.
Publicado: (2021) -
Small-molecule antagonist of VLA-4 (GW559090) attenuated neuro-inflammation by targeting Th17 cell trafficking across the blood-retinal barrier in experimental autoimmune uveitis
por: Chen, Yi Hsing, et al.
Publicado: (2021) -
Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis
por: Chen, Yi-Hsing, et al.
Publicado: (2022) -
T-bet Activates Th1 Genes through Mediator and the Super Elongation Complex
por: Hertweck, Arnulf, et al.
Publicado: (2016) -
Th22 cells in allergic disease
por: Eyerich, Kilian, et al.
Publicado: (2015)